Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2019)
The state of oncological care for the population of Russia in 2018. P.A. Gertzen Cancer Research Institute Moscow: Ministry of Health of Russian Federation
(2018)
The state of oncological care for the population of Russia in 2017
T. Mitin, C. Degnin, Yiyi Chen, S. Shirvani, E. Gillespie, S. Hoffe, K. Latifi, N. Nabavizadeh, N. Dengina, Marina Chernich, S. Usychkin, E. Kharitonova, Yu. Egorova, A. Pankratov, I. Tsimafeyeu, Charles Thomas, S. Tjulandin, A. Likhacheva (2018)
Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical ExpertiseJournal of Cancer Education, 35
N. O'Rourke, Marta Figuls, N. Bernadó, F. Macbeth (2010)
Concurrent chemoradiotherapy in non-small cell lung cancer.The Cochrane database of systematic reviews, 6
K. Miller, R. Siegel, C. Lin, A. Mariotto, J. Kramer, J. Rowland, K. Stein, Rick Alteri, A. Jemal (2016)
Cancer treatment and survivorship statistics, 2016CA: A Cancer Journal for Clinicians, 66
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)
Global Cancer Statistics
A. Aupérin, C. Péchoux, E. Rolland, W. Curran, K. Furuse, P. Fournel, J. Belderbos, G. Clamon, H. Ulutin, R. Paulus, T. Yamanaka, M. Bozonnat, A. Uitterhoeve, Xiaofei Wang, L. Stewart, R. Arriagada, S. Burdett, J. Pignon (2010)
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 13
N. Hanna, M. Neubauer, C. Yiannoutsos, R. Mcgarry, J. Arseneau, R. Ansari, C. Reynolds, R. Govindan, A. Melnyk, W. Fisher, D. Richards, D. Bruetman, T. Anderson, N. Chowhan, S. Nattam, Prasad Mantravadi, Cynthia Johnson, T. Breen, Angela White, L. Einhorn (2008)
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 35
N. Hanna (2008)
Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group BYearbook of Oncology, 2008
T. Mitin, N. Dengina, M. Chernykh, S. Usychkin, O. Gladkov, C. Degnin, Yiyi Chen, D. Nosov, I. Tsimafeyeu, Charles Thomas, S. Tjulandin (2019)
Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical ExpertiseJournal of Cancer Education, 36
S. McClelland, M. Chernykh, N. Dengina, E. Gillespie, A. Likhacheva, S. Usychkin, A. Pankratov, E. Kharitonova, Yu. Egorova, I. Tsimafeyeu, S. Tjulandin, Charles Thomas, T. Mitin (2018)
Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in RussiaJournal of Cancer Education, 34
A. Likhacheva, T. Mitin, E. Khmelevsky (2017)
The Red Beam: Past, Present, and Future of Radiation Oncology in Russia.International journal of radiation oncology, biology, physics, 97 2
C. Belani, H. Choy, P. Bonomi, C. Scott, P. Travis, J. Haluschak, W. Curran (2005)
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 25
S. Antonia, A. Villegas, D. Daniel, D. Vicente, S. Murakami, R. Hui, T. Yokoi, A. Chiappori, K. Lee, M. Wit, B. Cho, M. Bourhaba, X. Quantin, T. Tokito, T. Mekhail, D. Planchard, Young‐Chul Kim, C. Karapetis, S. Hiret, G. Ostoros, K. Kubota, J. Gray, L. Paz-Ares, J. Carpeño, C. Wadsworth, G. Melillo, Haiyi Jiang, Yi-fan Huang, P. Dennis, M. Özgüroğlu (2017)
Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung CancerThe New England Journal of Medicine, 377
A. Fernandes, Jason Shen, J. Finlay, N. Mitra, T. Evans, J. Stevenson, C. Langer, Lilie Lin, S. Hahn, E. Glatstein, R. Rengan (2010)
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 95 2
(2019)
Malignant neoplasms in Russia in 2018 (morbidity and mortality)
Cyrus Chargari, J. Soria, E. Deutsch (2013)
Controversies and challenges regarding the impact of radiation therapy on survival.Annals of oncology : official journal of the European Society for Medical Oncology, 24 1
Lindsey Torre, F. Bray, R. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal (2015)
Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 65
E. Vokes, J. Herndon, M. Kelley, M. Cicchetti, N. Ramnath, H. Neill, J. Atkins, D. Watson, W. Akerley, M. Green (2007)
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 13
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)
Global cancer statisticsCA: A Cancer Journal for Clinicians, 61
SI Jalal, HD Riggs, A Melnyk, D Richards, A Agarwala, M Neubauer, R Ansari, R Govindan, D Bruetman, W Fisher, T Breen, CS Johnson, M Yu, L Einhorn, N Hanna (2012)
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US OncologyAnn Oncol, 23
A Likhacheva (2017)
220IJROBP, 97
C. Aggarwal, Linna Li, H. Borghaei, R. Mehra, N. Somaiah, A. Turaka, C. Langer, G. Simon (2014)
Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.Cancer control : journal of the Moffitt Cancer Center, 21 1
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
BackgroundDefinitive concurrent chemoradiation (cCRT) is offered to only 3% of Russian patients with stage III NSCLC. To determine the patterns of care and barriers to cCRT utilization in Russia, we conducted a survey of practicing radiation oncologists (ROs).MethodsElectronic IRB-approved survey containing 15 questions was distributed to Russian ROs. Fisher’s exact test or Cochran-Armitage test of trend was used to assess the associations between clinical experience, practice type, and patterns of care.ResultsWe analyzed 58 questionnaires completed by ROs—16 respondents from tertiary referral hospitals, and 42 from community or private centers. A total of 88% of respondents formulate treatment recommendations in multi-disciplinary tumor boards. For unresectable stage III NSCLC, the most common recommendation is sequential CRT (50%), followed by concurrent CRT (40%), with an observed higher utilization of cCRT in tertiary centers (9/16, 56% vs 14/42, 33%). Of the respondents, 31% do not offer cCRT to their pts. Among reasons for avoiding cCRT are (1) poor performance of pts (76%); (2) high toxicity of therapy (55%); (3) lack of consensus among tumor board members (33%); and (4) preference for sequential CRT (31%). Only 3% do not irradiate elective LNs. Eighty-six percent of respondents counsel their NSCLC pts regarding smoking cessation.ConclusionsDespite level 1 evidence, cCRT is rarely used in Russia for pts with locally advanced NSCLC, and preference for sequential therapy and concerns over high toxicity are the most common barriers. Education of Russian ROs may increase cCRT utilization, leading to improved survival, notably in the era of maintenance immunotherapy.
Journal of Cancer Education – Springer Journals
Published: Oct 1, 2022
Keywords: Chemoradiation therapy; Non-small cell lung cancer; Russia
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.